Metraipolis › archive › dc_fd50d7967252

Engineered zero-order drug release from degradable PEG hydrogels - A rapamycin case study — Europe PMC PMID:41493349

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41493349
DOI
10.1177/08853282251410673
License (as archived)
solo-consultazione
Archived
2026-11-07T01:06:07.259Z
SHA-256 of the archived text
b518c3f748165a711d7ec2f62c07c59e6926f5d9572c1b0744c6da707264e074
Stable URL of this page
https://metraipolis.com/documento/dc_fd50d7967252

How to cite

Engineered zero-order drug release from degradable PEG hydrogels - A rapamycin case study — Europe PMC PMID:41493349 — Europe PMC (en), https://europepmc.org/article/MED/41493349 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fd50d7967252 (Metraipolis archive dc_fd50d7967252, sha256 b518c3f748165a711d7ec2f62c07c59e6926f5d9572c1b0744c6da707264e074)
BibTeX
@misc{dcfd50d7967252,
  title = {Engineered zero-order drug release from degradable PEG hydrogels - A rapamycin case study — Europe PMC PMID:41493349},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41493349},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fd50d7967252; sha256 b518c3f748165a711d7ec2f62c07c59e6926f5d9572c1b0744c6da707264e074},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41493349. Agents can read the archived copy with the MCP tool read_document.